What is more, the concentrations of GZMA in patients with ovarian cancer were substantially increased in comparison to that in patients with ovarian cystadenomas or ovarian teratomas (34), which is similar to our results that the high expression of GZMA was connected with poor OS of COAD patients. The gene discussed is GZMA; the disease is ovarian cystadenoma.